Intellia's Q1 net loss widens as CRISPR biotech misses earnings expectations
06 May 2021 - 10:10PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Intellia Therapeutics (NASDAQ:NTLA)
Historical Stock Chart
From Apr 2024 to May 2024
Intellia Therapeutics (NASDAQ:NTLA)
Historical Stock Chart
From May 2023 to May 2024